Regulatory News
Monday, July 11, 2016
BRIEF-Dale Chappell reports 33.2 pct stake in Kalobios Pharmaceuticals
* Dale Chappell reports 33.2 percent stake in Kalobios
Pharmaceuticals inc as of June 30 - SEC filing
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment